Dow Jones
39.164,06 +36,26 (+0,09%) Nasdaq
17.858,68 +53,53 (+0,30%) Nikkei 225
39.509,75 +168,21 (+0,43%) EUR/USD
1,0693 -0,0016 (-0,15%) Bitcoin EUR
57.519,95 +578,41 (+1,02%) CMC Crypto 200
1.283,36 +17,22 (+1,36%)
Pharming Group N.V. (PHAR)
| Chiusura precedente | 8,05 |
| Aperto | 8,14 |
| Denaro | 0,00 x 0 |
| Domanda | 0,00 x 0 |
| Min-Max giorno | 7,61 - 8,14 |
| Intervallo di 52 settimane | 6,97 - 16,71 |
| Volume | |
| Media Volume | 4.682 |
| Capitalizzazione | 546,3M |
| Beta (mensile su 5 anni) | 0,72 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,16 |
| Prossima data utili | 01 ago 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswirePharming Group to report third quarter 2023 financial results on October 26
Leiden, The Netherlands, October 12, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third quarter 2023 financial results, for the period ended September 30, on Thursday, October 26, 2023. Pharming will host a presentation for analysts and investors at 13:30 CEST/07:30 EDT on October 26, 2023. To participate in the conference call, please register in advance using the link below. Once registered, dial-in informat
- GlobeNewswire
Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
Leiden, The Netherlands, September 25, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted all proposals on the EGM agenda. Shareholders approved the appointment of Dr. Richard Peters as Non-Executive director for a period of four years. As a result, Dr. Peters succeeds Mr. Paul Sekhri as Chair of the Board of Directors with immediate effect. Deborah Jorn, Vice-Chair of the
